Sun Pharmaceutical Industries Ltd Share Price
As of 17 Sept 2026, Sun Pharmaceutical Industries Ltd share price is ₹1,853.50. The stock opened at ₹1,853.50 and had closed at ₹1,835.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,547.25 and a high of ₹2,047.55. In terms of performance, Sun Pharmaceutical Industries Ltd share price has increased by 2.19% over the past six months and has increased by 11.29% over the last year.
SUNPHARMA Stock Price Chart
Sun Pharmaceutical Industries Ltd Overview
About SUNPHARMA
Sun Pharmaceuticals Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical ingredients.
Sun Pharmaceutical Industries Ltd Historical Performance
SUNPHARMA Futures & Options
Sun Pharmaceutical Industries Ltd Fundamentals
Sun Pharmaceutical Industries Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 21,173.97 | 23,356.54 | 20,740.93 | 21,091.17 | 16,543.90 |
| EBITDA | 6,053.68 | 7,216.84 | 5,834.35 | 3,814.10 | 2,044.91 |
| Net Profit | 2,623.42 | 4,228.08 | 2,858.18 | 1,690.72 | -99.99 |
| EPS | 10.90 | 17.60 | 11.90 | 7.00 | -0.40 |
Sun Pharmaceutical Industries Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,823.75 |
| Resistance 1 (R1) | 1,851.30 |
| Pivot Point | 1,840.05 |
Sun Pharmaceutical Industries Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 07-Jul-2026 | 22-May-2026 | 07-Jul-2026 | Final | ₹5.00 |
| 05-Feb-2026 | 31-Jan-2026 | 05-Feb-2026 | Interim | ₹11.00 |
| 07-Jul-2025 | 22-May-2025 | 07-Jul-2025 | Final | ₹5.50 |
| 06-Feb-2025 | 31-Jan-2025 | 06-Feb-2025 | Interim | ₹10.50 |
| 12-Jul-2024 | 22-May-2024 | 12-Jul-2024 | Final | ₹5.00 |
SUNPHARMA Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Dilip S Shanghvi | Chairman |
| Kirti Wardhaman Ganorkar | Managing Director |
| Pawan Goenka | Non Executive Independent Director |
Sun Pharmaceutical Industries Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Divis Laboratories LtdDIVISLAB | ₹9,158.00-0.43% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,812.50-0.77% | ₹1,46,951.32 | 64.68 | 25.49% |
| Dr Reddys Laboratories LtdDRREDDY | ₹1,140.00-0.44% | ₹1,07,764.93 | 19.51 | 11.07% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Sun Pharmaceutical Industries Ltd today is ₹1,853.50 on NSE and ₹1,853.50 on BSE.
- The 52-week high of Sun Pharmaceutical Industries Ltd is ₹2,047.55, while the 52-week low is ₹1,547.25.
- The current market capitalisation of Sun Pharmaceutical Industries Ltd is approximately ₹4,40,278 crore.
- The P/E (Price-to-Earnings) ratio of Sun Pharmaceutical Industries Ltd is 38.32. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Sun Pharmaceutical Industries Ltd is 5.39. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Sun Pharmaceutical Industries Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for SUNPHARMA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Sun Pharmaceutical Industries Ltd has delivered a return of approximately 59.59%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Sun Pharmaceutical Industries Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 54.48% promoters, 1.69% FIIs, 22.18% DIIs, and 5.48% public shareholders.

